絞り込み

16639

広告

How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism.

著者 Chan NC , Eikelboom JW
Blood.2019 Mar 29 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (12view , 0users)
Anticoagulant therapy is the most effective strategy to prevent arterial and venous thromboembolism but treating older individuals is challenging because increasing age, comorbidities and polypharmacy increase the risk of both thrombosis and bleeding. Warfarin and the non-vitamin K antagonist oral anticoagulants are underused and often under-dosed in the prevention of stroke in older patients with atrial fibrillation because of concerns about the risk of bleeding. Poor adherence to anticoagulant therapy is also an issue for older patients with atrial fibrillation and for those at risk of recurrent pulmonary embolism. In this review, we present 5 clinical cases to illustrate common challenges with anticoagulant use in older patients and discuss our approach to institute safe and effective antithrombotic therapy.
PMID: 30926593 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード